Nkarta, Inc. (NKTX)

2.69 -0.07 (-2.54%) USD  |  NASDAQ  |  Aug 31, 10:27
More

Nkarta Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for NKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 17, 2026 --
August 13, 2026 --
August 11, 2026 --
June 23, 2026 --
June 22, 2026 --
May 13, 2026 --
May 12, 2026 --
April 16, 2026 --
April 10, 2026 --
March 26, 2026 --
February 20, 2026 --
November 11, 2025 --
August 13, 2025 --
Date Value
July 31, 2025 --
June 09, 2025 --
May 15, 2025 --
May 08, 2025 --
March 27, 2025 --
February 21, 2025 --
February 13, 2025 --
November 08, 2024 --
August 16, 2024 --
August 14, 2024 --
August 13, 2024 --
May 31, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Unicycive Therapeutics, Inc. Upgrade
OnKure Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade